Silver Book Fact

Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.

Innovation in the Biopharmaceutical Pipeline: A multidimensional view. http://www.phrma.org/sites/default/files/pdf/2013innovationinthebiopharmaceuticalpipeline-analysisgroupfinal.pdf. Published 2013

Reference

Title
Innovation in the Biopharmaceutical Pipeline: A multidimensional view.
Publisher
Analysis Group
Publication Date
Published 2013
Authors
Long, G and J Works
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • New cancer treatments account for large percent of life expectancy gains
     
  • Approximately one third of men diagnosed with prostate cancer will opt for surgical treatment.  
  • Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.  
  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • Increased use of medical technology, like colonoscopy and sigmoidoscopy for colon cancer screening, could save $178.2 billion between 2010 and 2035.